109997 ⎘
dsDNA viruses; Details; Poxviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
SYNTHETIC CHIMERIC POXVIRUSES
#2NUCLEIC ACID-BASED UNIVERSAL VACCINE AND METHODS OF USE THEREOF
#3SYNTHETIC CHIMERIC POXVIRUSES
#4MULTIVALENT VIRAL PARTICLES
#5Use of Ectromelia Virus for Cancer Immunotherapy and Vaccines
#6Conditions Improving Poxvirus Stability
#7Prostate neoantigens and their uses
#8SYNTHETIC CHIMERIC POXVIRUSES
#9Vaccine delivery method
#10Method for generating recombinant poxviruses
#11Methods and Compositions for Enhancing Vaccine Immune Responses
#12Compositions and methods to enhance the immune system
#13Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
#14Triple vaccine against and avian encephalomyelitis virus and fowl pox virus
#15Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
#16Vaccine delivery method
#17Poxvirus-recombinants, compositions containing such recombinants, uses thereof, and methods of making and using the same
#18Multivalent recombinant SPV
#19Synthetic chimeric poxviruses
#20Salmon gill poxvirus
#21Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#22Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine
#23Compositions and methods to enhance the immune system
#24Thermostable vaccines based on ether lipids and native viral envelope proteins
#25Poxviral vaccines
#26Stable liquid vaccinia virus formulations
#27Compositions and methods to enhance the immune system
#28Newcastle disease virus vectored avian vaccines
#29Treatment and prevention of malaria
#30VACCINE DELIVERY METHOD
#31Compositions and methods to enhance the immune system
#32Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
#33Compositions and methods to enhance the immune system
#34Single high dose of MVA induces a protective immune response in neonates and infants
#35Methods and compositions for enhancing vaccine immune responses
#36POXVIRUS-PLASMODIUM RECOMBINANTS, COMPOSITIONS CONTAINING SUCH RECOMBINANTS, USES THEREOF, AND METHODS OF MAKING AND USING SAME
#37Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#38Inactivating pathogens with oxidizing agents for vaccine production
#39Compositions and methods to enhance the immune system
#40Inactivating pathogens with oxidizing agents for vaccine production
#41Protein vaccines against poxviruses
#42Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
#43Compositions and methods to enhance the immune system
#44Newcastle disease virus vectored avian vaccines
#45Protein vaccines against poxviruses
#46Chemically defined vaccine stabiliser
#47VACCINE FOR IN OVO INOCULATION
#48Methods and compositions for vaccination
#49Immunological compositions
#50Inactivating pathogens with oxidizing agents for vaccine production
#51Stabilizers for veterinary vaccines
#52Compounds, compositions and methods for the treatment of poxvirus infections
#53Poxvirus containing formulations and process for preparing stable poxvirus containing compositions